Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Journal of Infectious Diseases & Therapy received 1529 citations as per Google Scholar report
Jack Ho WONG and Tzi Bun NG
ScientificTracks Abstracts: J Infect Dis Ther
In this study, synthetic bovine lactoferricin (Lfcin B) 17-30 and lactoferrampin (Lfampin B) 265-284 were tested for
antifungal activity against planktonic Candida albicans strain SC5314. Exposure of fungal cells to Lfcin B 17-30 brought
about morphological changes demonstrating the presence of vesicles upon pseudohyphae or hyphae; alterations of plasma
membrane permeability; and several hallmarks of apoptosis comprising phosphatidylserine externalization, reactive oxygen
species (ROS) production, DNA fragmentation, changes in mitochondrial membrane potential and activation of caspase.
From the aspect of gene expression, Lfcin B 17-30 probably brought about ROS accumulation by suppressing the expression of
superoxide dismutase 3 (SOD3). In addition, the suppression of gene FRE7, CTR1 and SIT1 may be associated with changes
of plasma membrane permeability. The minimal fungicidal concentration of Lfampin B 265-284 was determined to be 77.5μg/
ml against C. albicans cells at a concentration of 1x107 cell/ml. Lfampin B 265-284 exerted its antifungal effect mainly through
necrosis and apoptosis. Lfampin B 265-284 brought about changes in the fungal membrane permeability and mitochondrial
membrane potential and caspase activation. Treatment with Lfampin B 265-284 for 3 hours led to suppression of GPX2 and
increase of PXP2, which are both related to oxidative stress.
This work was supported by National Science Foundation of China research grants (No. 81201270 and 81471927).
Jack Ho WONG received his PhD degree in biochemistry from the Chinese University of Hong Kong in 2005. He serves as a research associate in the Faculty of
Medicine and Shenzhen Research Institute, CUHK. He has worked on defense proteins/peptides for over 10 years. His research encompasses: (i) antimicrobial
peptides and (ii) antitumor proteins/peptides. He has published more than 80 papers in peer-reviewed journals.
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals